ArticleCurrent oncology (Toronto, Ont.)2023

Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis.

Kuan-Chun Hsueh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.